The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. [electronic resource]
Producer: 20120103Description: 2517-30 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Antineoplastic Agents -- economics
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant -- economics
- Cost-Benefit Analysis
- Cyclophosphamide -- economics
- Docetaxel
- Epirubicin -- economics
- Female
- Fluorouracil -- economics
- Health Care Costs
- Humans
- Methotrexate -- economics
- Middle Aged
- Prognosis
- Quality-Adjusted Life Years
- Taxoids -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.